In Vitro Bioactivity Evaluation of IL ‐4 and SDF ‐1 Mimicking Peptides Engineered to Enhance Skeletal Muscle Reconstruction
Journal of Biomedical Materials Research Part A · 2025
DOI: 10.1002/jbm.a.37898 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, 2025. Verfasst von Zuzanna Michalska und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cytology, Institute of Developmental Biology and Biomedical Sciences, Faculty of Biology, University of Warsaw, Warsaw, Poland. Hauptthemen laut MEDLINE: Chemokine CXCL12, Interleukin-4, Muscle, Skeletal, Peptides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowe Centrum Nauki.
Abstract (Originalsprache)
Skeletal muscle regeneration depends on satellite cells, which, in response to injury, activate, proliferate, and reconstruct damaged tissue. However, under certain conditions, such as large injuries or myopathies, this process may not be properly executed, and muscle function may be affected. Thus, pro‐regenerative actions, such as the use of various factors or cells, are widely tested as a tool to improve muscle regeneration. In the current study, we designed peptides derived from the IL‐4 and SDF‐1 proteins, namely IL‐4‐X, IL‐4‐Y, SDF‐1‐X, and SDF‐1‐Y. We showed that these peptides can bind to appropriate receptors and can adopt proper structure in solution. Importantly, we documented, using in vitro culture, that they do not negatively affect the cells that are present and active in skeletal muscles, such as myoblasts and fibroblasts, bone marrow stromal cells, as well as induced pluripotent stem cells, which can serve as a source of myoblasts. The presence of peptides did not affect cell proliferation compared to untreated cells. In vitro culture and differentiation protocols documented that selected IL‐4 and SDF‐1 peptides increased cell migration and inhibited undesirable adipogenic differentiation. Thus, we proved that these peptides are safe to use in in vivo studies aimed at improving skeletal muscle regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cytology, Institute of Developmental Biology and Biomedical Sciences, Faculty of Biology, University of Warsaw, Warsaw, Poland.
- Department of Biomedical Chemistry, Faculty of Chemistry, University of Gdańsk, Gdańsk, Poland.
- Department of Theoretical Chemistry, Faculty of Chemistry, University of Gdańsk, Gdańsk, Poland.
ORCID-Profile: Zuzanna Michalska, Anna Ostaszewska, Martyna Fularczyk, Maria Dzierżyńska, Kacper Bielak, Adam K Sieradzan, Karolina Archacka, Edyta Brzoska, Sylwia Rodziewicz-Motowidło, Maria A Ciemerych
Förderung
- Narodowe Centrum Nauki
Zitieren
APA
Michalska, Z., Ostaszewska, A., Fularczyk, M., Dzierżyńska, M., Bielak, K., Morytz, J., Sieradzan, A. K., Archacka, K., Brzoska, E., Rodziewicz-Motowidło, S., & Ciemerych, M. A. (2025). In Vitro Bioactivity Evaluation of IL ‐4 and SDF ‐1 Mimicking Peptides Engineered to Enhance Skeletal Muscle Reconstruction. Journal of Biomedical Materials Research Part A. https://doi.org/10.1002/jbm.a.37898
Vancouver
Michalska Z, Ostaszewska A, Fularczyk M, Dzierżyńska M, Bielak K, Morytz J, et al. In Vitro Bioactivity Evaluation of IL ‐4 and SDF ‐1 Mimicking Peptides Engineered to Enhance Skeletal Muscle Reconstruction. Journal of Biomedical Materials Research Part A. 2025. doi:10.1002/jbm.a.37898
BibTeX
@article{Michalska2025,
author = {Michalska, Zuzanna and Ostaszewska, Anna and Fularczyk, Martyna and Dzierżyńska, Maria and Bielak, Kacper and Morytz, Justyna and Sieradzan, Adam K and Archacka, Karolina and Brzoska, Edyta and Rodziewicz-Motowidło, Sylwia and Ciemerych, Maria A},
title = {In Vitro Bioactivity Evaluation of IL ‐4 and SDF ‐1 Mimicking Peptides Engineered to Enhance Skeletal Muscle Reconstruction},
journal = {Journal of Biomedical Materials Research Part A},
year = {2025},
doi = {10.1002/jbm.a.37898}
}
EUVIMED